Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Voyageur Pharmaceuticals Ltd
VYYRF
Primary Symbol:
V.VM
Healthcare
Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX...
, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:VM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 24, 2024 9:01am
New Press Release - Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
(TheNewswire)Calgary, Alberta, Canada – TheNewswire - September 24, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") is pleased to announce the appointment of Dr. Ibrahim Hashmi as Vice President of Business Development, as key strategic move that...
read article.
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Sep 19, 2024 11:46am
RE:RE:RE:This is why formulations took so long, great strategy!
since she knows the FDA maybe that is closer than we know. I am also wondering if that Vanadium/raincage stuff might be getting closer to advancement stage. Since VM is very closed mouth we will not
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Sep 19, 2024 11:38am
RE:RE:RE:RE:This is why formulations took so long, great strategy!
this youtube linkmight be allowed. On thelinked in close the pop up window and hit the rorple link also Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Sep 19, 2024 11:29am
RE:RE:RE:This is why formulations took so long, great strategy!
You need to go to Proactive Investor website, and watch the latest interview with Voyageur. The link is blocked by Stockhouse, as they are a competitor. Obviously Voyageur is using multiple marketing
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Sep 19, 2024 11:24am
RE:RE:This is why formulations took so long, great strategy!
https://www.paidpromotionalmessages.com/companies/news/1056486/voyageur-pharmaceuticals-announces-new-line-of-barium-contrast-formulations-setting-new-standard-1056486.html
(94)
•••
Mbxwatcher
X
View Profile
View Bullboard History
Comment by
Mbxwatcher
on Sep 19, 2024 10:44am
RE:RE:This is why formulations took so long, great strategy!
https://www.paidpromotionalmessages.com/companies/news/1056486/voyageur-pharmaceuticals-announces-new-line-of-barium-contrast-formulations-setting-new-standard-1056486.html
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Sep 19, 2024 8:47am
RE:This is why formulations took so long, great strategy!
Could you copy and paste this article for those whom do not have an linkedin account please?
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Sep 19, 2024 8:43am
RE:A Great New Add to the Executive Team
Perhaps Dr Iryna Sarachova is the missing fullerene element to compliment the members of Voyageurs highly skilled Scientific Advisory Board: Deborah A. Baumgarten, MD, MPH Professor of
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Sep 18, 2024 8:11pm
RE:RE:This is why formulations took so long, great strategy!
Something has to break loose soon. You don't bring on a high profile CSO unless there is something cooking behind the scenes
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Sep 18, 2024 6:46pm
RE:This is why formulations took so long, great strategy!
That explains a lot. Plus VM still has the generics to fall back on. Should be a 20 yr. patent on these formulas and another company would have to find a natural deposit. Superior product and 20 yrs
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Sep 18, 2024 2:04pm
This is why formulations took so long, great strategy!
https://www.linkedin.com/feed/update/urn:li:activity:7242229253763710976/
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Sep 17, 2024 4:25pm
RE:RE:A Great New Add to the Executive Team
13.8%, Thats an interesting success rate.
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Sep 17, 2024 4:03pm
RE:A Great New Add to the Executive Team
There are probably many more failures than hits even by the best companies and scientists. I looked that up and if anybody thinks that a failure is a black mark on a persons' resume they had
...more
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Sep 17, 2024 2:23pm
A Great New Add to the Executive Team
The criticism from those lacking education is often surprisingly quick. The Chief Science Officer's previous tenure at a pharmaceutical company, despite unsuccessful drug trials, should not be
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden